1、该刊只有国际刊号。

2、投稿方式：官网投稿。

3、官网网址（微信公众号信息）：

https://journals.lww.com/cares/pages/default.aspx

4、投稿系统：

https://www.editorialmanager.com/cares/default.aspx

5、官网邮箱：CR@pub.hep.cn

6、出刊日期：季刊，一年出版四期。

7、官网信息：目前不收版面费。

8、官方微信公众号：CR2025（主办单位微信公众号信息）

2025年11月19日星期三

Cardiac Research征稿启事

【官方微信公众号信息】

CR2025 2025年2月27日

期刊简介

Cardiac Research是一本专注于心血管领域研究的国际学术期刊，旨在发表高质量的心血管基础研究、临床研究以及转化医学相关的原创性研究成果。期刊内容涵盖心血管疾病的基础机制、诊断技术、治疗策略以及疾病预防等多个方面，包括但不限于心血管疾病的基础研究、临床与流行病学研究、遗传与生物信息学研究、影像学研究、转化医学及交叉学科研究等，致力于推动心血管医学的发展和创新。

Cardiac Research围绕多个前沿领域展开征稿，优先发表以下主题：

01心血管疾病流行病学

疾病负担的时空分布

社会经济影响评估

风险因素归因分析

医疗资源利用研究

疾病预测模型

02心血管医学的治疗创新

心血管疾病发病机制的新靶点

创新药物研发与评估

医疗器械技术的优化研究

个性化治疗方案的探索

03临床研究与心血管循证医学

随机对照试验的设计与实施

系统评价与荟萃分析

真实世界证据研究

临床决策分析

预后研究

04心血管研究的方法学创新

新型生物信息学工具的应用

人工智能与机器学习

实验技术的优化与标准化

临床研究的创新分析方法

05心血管疾病的早期预防

生物标志物研究

遗传风险评估

早期筛查策略

预防医学研究

06高血压与血管疾病研究

致病靶点及机制研究

靶器官损伤研究

治疗策略优化

07心血管康复与二级预防

康复策略优化

生活方式干预研究

心理康复

长期预后评估

08心血管医学指南与临床实践

心血管疾病诊疗指南的发布与解读

Cardiac Research坚持“心起点、新视野”的办刊理念，为全球心血管研究者提供一个高水平的学术交流平台，促进基础研究、临床实践和转化医学的深度融合，推动心血管医学的创新发展。

Instructions for Authors

【官网信息】

The

Editorial Office is pleased to answer any questions you may have about

preparing your manuscript in accordance with our guidelines.

Email: CR@pub.hep.cn

AIMS AND SCOPE

Cardiac

Research is a pioneering open-access journal dedicated to advancing the

field of cardiovascular science. The journal encompasses a broad

spectrum of research areas, including fundamental molecular discoveries,

genetic and genomic investigations, advanced imaging technologies,

translational research, clinical trials, and epidemiological studies in

cardiovascular diseases. Our mission is to publish cutting-edge research

that enhances our understanding of cardiovascular physiology and

pathology, while fostering innovations in preventive strategies and

therapeutic interventions. Through a rigorous peer-review and editorial

process, we maintain the highest standards of scientific integrity and

academic excellence.

ONLINE SUBMISSION

First-time Users

Please

click the Register button at

https://www.editorialmanager.com/cares/default.aspx. Upon successful

registration, you will be sent an email providing your username and

password. Save this information for future reference.

Note:

If you have received an email from us with an assigned username and

password, or if you are a repeat user, do not register again. Once you

have an assigned username and password, you do not have to re-register.

Authors

Please

click the Login button from the menu at the top of the page and login

to the system as an author. Submit your manuscript according to the

author instructions. You will be able to track the process of your

manuscript through the system.

JOURNAL

POLICIES Duplicate Publication Manuscripts are reviewed for possible

publication with the understanding that they are being submitted only to

the Cardiac Research and have not been published, simultaneously

submitted, or already accepted for publication elsewhere. The Editorial

team may subject any manuscript submitted for consideration of

publication in the Cardiac Research to plagiarism-detection software.

This

does not preclude consideration of a manuscript that has been rejected

by another journal or a complete report that follows publication of

preliminary findings elsewhere, usually in the form of an abstract.

Copies of any possibly duplicate published material should be submitted

with the manuscript under consideration, with a statement in the cover

letter as to why the manuscript currently being submitted is not a

duplicate publication.

Disclosure of Conflicts

Authors

must state all possible conflicts of interest in the manuscript,

including financial, consultant, institutional and other relationships

that might lead to bias or a conflict of interest. If there is no

conflict of interest, this should also be explicitly stated as none

declared. All sources of funding should be acknowledged in the

manuscript.

All

relevant conflicts of interest and sources of funding should be

included on the title page of the manuscript with the heading "Conflicts

of Interest" and "Source of Funding".

For

example: "Conflicts of Interest: A has received honoraria from Company

Z. B is currently receiving a grant (#12345) from Organization Y, and is

on the speaker's bureau for Organization X - the CME organizers for

Company A. For the remaining authors none were declared."

"Source of Funding": list all the grant supports/funders for the study.

A

financial disclosure section is part of the submission process and must

be completed by each author at first revision. This information is for

review by the Editors but will be published if relevant to the content

of the accepted manuscript.

The

primary purpose of the disclosure section is to determine whether

authors have received any commercial financial support that could create

a conflict of interest. In addition to monetary interests, a potential

for conflict of interest can exist whether or not an individual believes

that a relationship (such as dual commitments, competing interests, or

competing loyalties) affects his or her scientific judgment. Please

review ICMJE Uniform Requirements for Manuscripts Submitted to

Biomedical Journals at the following link:

http://www.icmje.org/conflicts-of-interest.

Studies in Humans and Animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

Authors

should include a statement in the manuscript that informed consent was

obtained for experimentation with human subjects. The privacy rights of

human subjects must always be observed.

Authors

describing studies involving animals must have consulted the ' Animal

Research: Reporting In Vivo Experiments' (ARRIVE) 2.0 guidelines,

developed by the NC3Rs to improve standards of reporting, ensuring that

the data from animal experiments can be fully scrutinized and utilized.

Articles reporting in vivo experiments must adhere to the ARRIVE

Essential 10 checklist as a minimum, and we encourage authors to use the

full ARRIVE 2.0 checklist. The relevant information outlined in these

guidelines should be included in the appropriate section of the article.

Ethics

When

reporting studies on human subjects, author should indicate whether the

procedures followed were in accordance with the ethical standards of

the responsible committee on human experimentation (institutional or

regional) and with the Declaration of Helsinki (

https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

). For prospective studies involving human participants, authors are

expected to mention about approval of regional/national/institutional or

independent ethics committee or review board, obtaining informed

consent from adult research participants and obtaining assent for

children aged over 7 years participating in the trial. The age beyond

which assent would be required could vary as per regional and/or

national guidelines. Ensure confidentiality of subjects by desisting

from mentioning participants' names, initials or hospital numbers,

especially in illustrative material. When reporting experiments on

animals, indicate whether the institution's or a national research

council's guide for, or any national law on the care and use of

laboratory animals was followed.

Evidence

for approval by a local ethics committee (for both human as well as

animal studies) must be supplied by the authors on demand. Animal

experimental procedures should be as humane as possible, and the details

of anesthetics and analgesics used should be clearly stated. The

ethical standards of experiments must be in accordance with the

guidelines provided by the ARRIVE and World Medical Association

Declaration of Helsinki on Ethical Principles for Medical Research

Involving experimental animals and human beings, respectively. The

journal will not consider any paper which is ethically unacceptable. A

statement on ethics committee permission and ethical practices must be

included in all research articles under the "Methods" section.

We

reserve the right to decline publication of a paper even after it has

been accepted if it becomes apparent that there are serious problems

with the scientific content or violations of our publishing policies.

Protection of Patients' Rights to Privacy

Identifying

information should not be published in written descriptions,

photographs, sonograms, CT scans, etc., and pedigrees unless the

information is essential for scientific purposes and the patient (or

parent or guardian, wherever applicable) gives written informed consent

for publication. Authors should remove patients' names from figures

unless they have obtained written informed consent from the patients.

The journal abides by ICMJE guidelines: (1) Authors, not the journals

nor the publisher, need to have the patient consent form before the

publication related to patient privacy and have the form properly

archived by the author. (2) If the publication includes some facial

images that make the patients identifiable, a statement about the

patient's consent needs to be present in the manuscript.

Data Availability Statement

Cardiac

Research requires authors to include in any articles that report

results derived from research data to include a Data Availability

Statement. The provision of a Data Availability Statement will be

verified as a condition of publication. Data Availability Statements

should include information on where data supporting the results reported

in the article can be found including, where applicable, hyperlinks to

publicly archived datasets analyzed or generated during the study. Where

research data are not publicly available, this must be stated in the

manuscript along with any conditions for accessing the data. Data

Availability Statements must take one of the following forms (or a

combination of more than one if required for multiple types of research

data):

The

datasets generated during and/or analyzed during the current study are

available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]

The

datasets generated during and/or analyzed during the current study are

not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are

available from the corresponding author on reasonable request.

The

datasets generated during and/or analyzed during the current study are

available from the corresponding author on reasonable request.

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

All

data generated or analyzed during this study are included in this

published article [and its supplementary information files].

The

data that support the findings of this study are available from [third

party name] but restrictions apply to the availability of these data,

which were used under license for the current study, and so are not

publicly available. Data are however available from the authors upon

reasonable request and with permission of [third party name].

AUTHORSHIP

Cardiac

Researchexpects that each person listed as an author has participated

sufficiently in the intellectual content, the analysis of data, and/or

the writing of the manuscript to take public responsibility for it. Each

author must have reviewed the manuscript, believes it represents valid

work, and approves it for submission.

Moreover,

should the Editorial team request the data upon which the manuscript is

based, the authors shall produce it. Each author's specific

contributions to the work should be indicated; this information will be

published as a footnote to the paper. For example, the areas of

participation might include:

Participated in research design

Participated in the writing or critical revision of the paper

Participated in the performance of the research

Contributed new reagents or analytic tools

Participated in data analysis

An

author may list more than one contribution, and more than one author

may have contributed to the same aspect of the work. Any change in

authorship/contributions after submission must be approved in writing by

all authors and submitted to the Editorial Office for final

consideration.

Authors

are fully responsible for the content of their manuscript, even those

parts produced by GenAI. Authors who have used GenAI in their research

and the writing of manuscripts should provide an open, transparent, and

detailed description of the use of GenAI (including the name and version

of the GenAI tool, when it was used, how it was used, and the process

of using it, and, if necessary, annotations for AI-assisted contents

dealing with facts and opinions), and review of GenAI, following the

body of the text, before the references, or in the method section (e.g.,

the authors have reviewed and edited the GenAI-produced content, and

take full responsibility for the authenticity and accuracy of the

content of this paper). It is recommended that authors submit and

archive the GenAI-assisted sections (text, figures, programs, etc.) as

supplementary material so that reviewers and editors can judge the

accuracy, integrity，and originality of the paper.

Since

GenAI cannot meet the requirements for authorship as they cannot take

responsibility for the submitted work, GenAI -related products and

developing teams cannot be listed as the author of a paper.

GenAI

cannot be used to write an entire paper or a significant portion of a

paper (e.g., method, result and analysis, etc.). All content that falls

under the category of scientific contribution or intellectual labor

should be finished by the author. If the main content of the paper is

completed using GenAI, the editorial office will handle it as academic

misconduct.

......

更多详情：

https://journals.lww.com/cares/Pages/informationforauthors.aspx